Literature DB >> 17962195

Gain-of-function mutation in TRPML3 causes the mouse Varitint-Waddler phenotype.

Hyun Jin Kim1, Qin Li, Sandra Tjon-Kon-Sang, Insuk So, Kirill Kiselyov, Shmuel Muallem.   

Abstract

TRPML3 is a member of the TRPML subfamily of the transient receptor potential cation channel superfamily. The TRPML3(A419P) mutation causes a severe form, whereas the TRPML3(I362T/A419P) mutation results in a mild form of the varitint-waddler phenotype. The channel properties of TRPML3 and how the mutations cause each phenotype are not known. In this study, we report the first channel properties of TRPML3 as a strongly inward rectifying cation channel with a novel regulation by extracytosolic Na+. Preincubating the extracytosolic face of TRPML3 in Na+-free medium is required for channel activation, but then the channel slowly inactivates. The A419P mutation locks the channel in an open unregulated state. Similar gain of function was observed with the A419G mutation, which, like A419P, is expected to destabilize the alpha-helical fifth transmembrane domain of TRPML3. The I362T mutation results in an inactive channel, but the channel properties of TRPML3(I362T/A419P) are similar to those of TRPML3(A419P). However, the surface expression and current density of TRPML3(I362T/A419P) are lower than those of TRPML3(A419P). The A419P mutation also affects channel glycosylation and causes massive cell death. These findings show that the varitint-waddler phenotype is due to a gain of function of TRPML3(A419P) that is reduced by the TRPML3(I362T/A419P) mutant, resulting in a milder phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962195     DOI: 10.1074/jbc.C700190200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy.

Authors:  David A Zeevi; Shaya Lev; Ayala Frumkin; Baruch Minke; Gideon Bach
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  Properties of the TRPML3 channel pore and its stable expansion by the Varitint-Waddler-causing mutation.

Authors:  Hyun Jin Kim; Soichiro Yamaguchi; Qin Li; Insuk So; Shmuel Muallem
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

4.  A helix-breaking mutation in the epithelial Ca(2+) channel TRPV5 leads to reduced Ca(2+)-dependent inactivation.

Authors:  Kyu Pil Lee; Anil V Nair; Christian Grimm; Femke van Zeeland; Stefan Heller; René J M Bindels; Joost G J Hoenderop
Journal:  Cell Calcium       Date:  2010-10-29       Impact factor: 6.817

5.  Opening the TRPML gates.

Authors:  Soichiro Yamaguchi; Shmuel Muallem
Journal:  Chem Biol       Date:  2010-03-26

6.  The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway.

Authors:  Jose A Martina; Benjamin Lelouvier; Rosa Puertollano
Journal:  Traffic       Date:  2009-04-29       Impact factor: 6.215

7.  Life and death of sensory hair cells expressing constitutively active TRPML3.

Authors:  Christian Grimm; Simone Jörs; Stefan Heller
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

Review 8.  TRPMLs: in sickness and in health.

Authors:  Rosa Puertollano; Kirill Kiselyov
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

Review 9.  The role of π-helices in TRP channel gating.

Authors:  Lejla Zubcevic; Seok-Yong Lee
Journal:  Curr Opin Struct Biol       Date:  2019-08-02       Impact factor: 6.809

Review 10.  Aberrant Ca2+ handling in lysosomal storage disorders.

Authors:  Kirill Kiselyov; Soichiro Yamaguchi; Christopher W Lyons; Shmuel Muallem
Journal:  Cell Calcium       Date:  2010-01-06       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.